CNBX Pharmaceuticals Inc. (CNBX) EPS (Basic) (2013 - 2026)
CNBX Pharmaceuticals' (CNBX) quarterly EPS (Basic) came in at -$0.0 in Q2 2026, up 90.36% YoY from -$0.0 in Q2 2025, and down 184.87% on a QoQ basis from -$0.0 in Q1 2026.
CNBX Pharmaceuticals Inc. (CNBX) EPS (Basic) (2013 - 2026) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 14 years of EPS (Basic) data on file, last reported at -$0.0 in Q2 2026.
- Quarterly EPS (Basic) rose 90.36% year-over-year to -$0.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$0.0 (up 42.16% YoY) and the FY2025 annual result came in at -$0.04, up 68.62% from the prior year.
- EPS (Basic) slipped to -$0.0 in Q2 2026, from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q1 2026 to a low of -$0.55 in Q2 2022.
- A 5-year average of -$0.08 and a median of -$0.01 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 8091.84% — and 2026, when it soared 97.98%.
- Tracing CNBX's EPS (Basic) over 5 years: stood at -$0.28 in 2022, then surged by 97.64% to -$0.01 in 2023, then surged by 80.55% to -$0.0 in 2024, then jumped by 88.28% to -$0.0 in 2025, then climbed by 17.98% to -$0.0 in 2026.
- The last three EPS (Basic) figures came in at -$0.0 (Q2 2026), -$0.0 (Q1 2026), and -$0.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 0.00 |
| Feb 28, 2026 | 0.00 |
| Nov 30, 2025 | 0.00 |
| Aug 31, 2025 | -0.04 |
| May 31, 2025 | 0.00 |
| Feb 28, 2025 | 0.00 |
| Nov 30, 2024 | 0.00 |
| Aug 31, 2024 | 0.00 |
| May 31, 2024 | 0.00 |
| Feb 29, 2024 | -0.01 |
| Nov 30, 2023 | -0.01 |
| Aug 31, 2023 | -0.02 |
| May 31, 2023 | -0.02 |
| Feb 28, 2023 | -0.13 |
| Nov 30, 2022 | -0.28 |
| Aug 31, 2022 | -0.40 |
| May 31, 2022 | -0.55 |
| Feb 28, 2022 | -0.01 |
| Nov 30, 2021 | -0.01 |
| Aug 31, 2021 | 0.00 |